BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17878127)

  • 1. Chemotherapy-related change in cognitive function: a conceptual model.
    Hess LM; Insel KC
    Oncol Nurs Forum; 2007 Sep; 34(5):981-94. PubMed ID: 17878127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the theory of unpleasant symptoms and the conceptual model of chemotherapy-related changes in cognitive function.
    Myers JS
    Oncol Nurs Forum; 2009 Jan; 36(1):E1-10. PubMed ID: 19136326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
    Myers JS; Pierce J; Pazdernik T
    Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-related cognitive change: a principle-based concept analysis.
    Kanaskie ML
    Oncol Nurs Forum; 2012 May; 39(3):E241-8. PubMed ID: 22543395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
    Schagen SB; Das E; van Dam FS
    Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
    Saykin AJ; Ahles TA; McDonald BC
    Semin Clin Neuropsychiatry; 2003 Oct; 8(4):201-16. PubMed ID: 14613048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
    Tannock IF; Ahles TA; Ganz PA; Van Dam FS
    J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of neuromuscular alterations in elders with cancer.
    Visovsky C
    Semin Oncol Nurs; 2006 Feb; 22(1):36-42. PubMed ID: 16458181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
    Vardy J; Rourke S; Tannock IF
    J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.
    Schagen SB; Das E; Vermeulen I
    Psychooncology; 2012 Oct; 21(10):1132-5. PubMed ID: 21769988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Knowledge and management of psychological side effects of chemotherapies].
    Auroy L; Eisinger F; Julian-Reynier C
    Bull Cancer; 2000 Jun; 87(6):463-7. PubMed ID: 10903788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice.
    Johnston MF; Yang C; Hui KK; Xiao B; Li XS; Rusiewicz A
    Integr Cancer Ther; 2007 Mar; 6(1):36-41. PubMed ID: 17351025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-related cognitive impairment.
    Myers JS
    Clin J Oncol Nurs; 2009 Aug; 13(4):413-21. PubMed ID: 19648097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.
    Schagen SB; Boogerd W; Muller MJ; Huinink WT; Moonen L; Meinhardt W; Van Dam FS
    Acta Oncol; 2008; 47(1):63-70. PubMed ID: 17934892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renaming "chemobrain".
    Hurria A; Somlo G; Ahles T
    Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study.
    Minisini AM; De Faccio S; Ermacora P; Andreetta C; Fantinel R; Balestrieri M; Piga A; Puglisi F
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):71-9. PubMed ID: 18394917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.